|
Contents
|
|
|
|
Astrocytic
Tumors
|
|
|
|
|
Liu
Z, Yao Z, Li C, Lu Y, Gao C.
Gene expression profiling in
human high-grade astrocytomas.
Comp Funct Genomics.
2011;2011:245137.
.JPG) Abstract |
.png)
Reprint |
.gif) Related articles
|
|
|
Brain Tumors
|
|
|
|
|
Crea
F, Hurt EM, Farrar WL.
Clinical significance of Polycomb gene expression in brain tumors.
Mol Cancer. 2010 Sep 30;9(1):265. [Epub ahead of print]
Abstract |
Reprint |
Related articles
|
|
|
Lee H, Kong SW, Park PJ
Integrative analysis reveals the direct and indirect interactions between
DNA copy number aberrations and gene expression changes
Bioinformatics. 2008 Feb 8; [Epub ahead of print]
Abstract
|
|
|
Glioblastoma
|
|
|
|
|
Bredel M, Scholtens DM, Yadav AK, Alvarez AA, Renfrow JJ, Chandler JP, Yu
IL, Carro MS, Dai F, Tagge MJ, Ferrarese R, Bredel C, Phillips HS, Lukac PJ,
Robe PA, Weyerbrock A, Vogel H, Dubner S, Mobley B, He X, Scheck AC, Sikic
BI, Aldape KD, Chakravarti A, Harsh GR.
NFKBIA
Deletion in Glioblastomas.
N
Engl J Med. 2010 Dec 22. [Epub ahead of print]
Abstract |
Reprint | .gif)
News
|
Related articles
|
|
|
Freire
P, Vilela M, Deus H, Kim YW, Koul D, Colman H, Aldape KD, Bogler O, Yung WK,
Coombes K, Mills GB, Vasconcelos AT, Almeida JS
Exploratory analysis of the copy number alterations in glioblastoma
multiforme
PLoS ONE. 2008;3(12):e4076. Published: December 30, 2008
Abstract | .png)
Full Text |
Reprint
|
|
|
Hulleman E, Quarto M, Vernell R, Masserdotti G,
Colli E, Kros JM, Levi D, Gaetani P, Tunici P, Finocchiaro G, Rodriguez Y
Baena R, Capra M, Helin K.
A role for the transcription factor HEY1 in glioblastoma
J Cell Mol Med. 2008 Mar 17; [Epub ahead of print]
Abstract |
Reprint
|
|
|
Kakkar A, Suri V, Jha P, Srivastava A, Sharma V, Pathak P, Sharma MC, Sharma
MS, Kale SS, Chosdol K, Phalak M, Sarkar C.
Loss of heterozygosity on chromosome 10q in glioblastomas, and its
association with other genetic alterations and survival in Indian patients.
Neurol India 2011;59:254-261. Epub 2011 Apr 7.
Abstract |
Full
text
|
|
|
Kaneshiro
D, Kobayashi T, Chao ST, Suh J, Prayson RA
Chromosome 1p and 19q Deletions in Glioblastoma Multiforme
Appl Immunohistochem Mol Morphol. 2009 Jul 13;. [Epub ahead of print]
Abstract
|
|
Kavsan
VM, Dmitrenko VV, Shostak KO, Bukreieva TV, Vitak NY, Simirenko OE,
Malisheva TA, Shamayev MI, Rozumenko VD, Zozulya YA.
Comparison of microarray and sage techniques in gene
expression analysis of human glioblastoma.
Tsitol Genet.
2007 Jan-Feb;41(1):36-55.
PMID: 17427416 [PubMed - in process]
|
|
|
Kleihues
P and Ohgaki H
Primary and secondary glioblastomas: From concept to
clinical diagnosis
Neuro-oncol 1999 January; 1(1): 44-51; DOI:10.1215/15228517-1-1-44
Abstract |
Reprint
|
|
|
Kleihues
P and Ohgaki H
Genetics of glioma progression and
the definition of primary and secondary glioblastoma
Brain Pathol. 7,1131–1136 (October
1997)
Abstract
|
|
|
Lo KC, Bailey D, Burkhardt T, Gardina P, Turpaz
Y, Cowell JK
Comprehensive analysis of loss of heterozygosity events in glioblastoma
using the 100K SNP mapping arrays and comparison with copy number
abnormalities defined by BAC array comparative genomic hybridization
Genes Chromosomes Cancer. 2007 Nov 29;. [Epub ahead of print]
Abstract
|
|
|
Ramon Martinez, Gabriele Schackert and
Manel Esteller
Hypermethylation of the proapoptotic gene TMS1/ASC: prognostic
importance in glioblastoma multiforme
J Neurooncol. 2006 Oct 18; [Epub
ahead of print]
Abstract
|
|
|
Nakamura H, Makino K, Kuratsu JI.
Molecular
and clinical analysis of glioblastoma with an oligodendroglial component
(GBMO).
Brain Tumor Pathol.
2011 Jun 1. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Nobusawa
S, Watanabe T, Kleihues P, Ohgaki H
IDH1
mutations as molecular signature and predictive factor of secondary
glioblastomas
Clin
Cancer Res. 2009 Oct 1;15(19):6002-7. Epub 2009 Sep 15
Abstract
|
|
|
Parsons DW.
The evolving picture of the glioblastoma genome.
Oncotarget. 2010 Aug;1(4):237-8.
Abstract |
Reprint |
Related articles
|
|
|
Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ,
Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, Olivi A, McLendon R,
Rasheed BA, Keir S, Nikolskaya T, Nikolsky Y, Busam DA, Tekleab H, Diaz LA
Jr, Hartigan J, Smith DR, Strausberg RL, Marie SK, Shinjo SM, Yan H, Riggins
GJ, Bigner DD, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B,
Velculescu VE, Kinzler KW.
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Science. 2008 Sep 4; [Epub ahead of print]
Abstract |
Reprint
|
|
Stéphan Saikali, Tony Avril, Brigitte Collet,
Abderrahmane Hamlat, Jean-Yves Bansard, Bernard Drenou, Yvon Guegan
and Véronique Quillien
Expression of nine tumour antigens in a series of human glioblastoma
multiforme: interest of EGFRvIII, IL-13Rα2, gp100 and TRP-2 for
immunotherapy
J Neurooncol. 2006 Sep 27; [Epub
ahead of print]
Abstract
|
|
|
Vital
AL, Tabernero MD, Castrillo A, Rebelo O, Tão H, Gomes F, Nieto AB, Resende
Oliveira C, Lopes MC, Orfao A.
Gene expression profiles of human glioblastomas are associated with both
tumor cytogenetics and histopathology
Neuro Oncol. 2010 May 18;. [Epub ahead of print]
Abstract
|
|
|
Wang LF, Fokas E, Juricko J, You A, Rose F,
Pagenstecher A, Engenhart-Cabillic R, An HX.
Increased expression of EphA7 correlates with adverse outcome in primary
and recurrent glioblastoma multiforme patients
BMC Cancer. 2008 Mar 25;8(1):79
Abstract |
Full Text |
Reprint
|
|
|
Gliomas
|
|
|
|
Batistatou A, Kyzas PA, Goussia A, Arkoumani E,
Voulgaris S, Polyzoidis K, Agnantis NJ, Stefanou D.
Estrogen receptor beta (ERbeta) protein expression correlates with BAG-1 and
prognosis in brain glial tumours.
J Neurooncol. 2006 Mar;77(1):17-23. Epub 2005 Nov 15.
Abstract
|
|
|
De
Witt Hamer PC, Van Tilborg AA, Eijk PP, Sminia P, Troost D, Van Noorden CJ,
Ylstra B, Leenstra S.
The genomic profile of human malignant glioma is altered early in primary
cell culture and preserved in spheroids.
Oncogene. 2007 Oct 15; [Epub ahead of print]
Abstract
|
|
|
Ohgaki
H, Kleihues P.
Genetic profile of astrocytic and oligodendroglial gliomas.
Brain Tumor Pathol. 2011 Mar 26;. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Gliomas
(High-Grade)
|
|
|
|
Arifin MT, Hama S, Kajiwara Y, Sugiyama K, Saito
T, Matsuura S, Yamasaki F, Arita K, Kurisu K.
Cytoplasmic, but not nuclear, p16 expression
may signal poor prognosis in high-grade astrocytomas.
J Neurooncol. 2006 May;77(3):273-7. Epub
2006 Apr 14.
Abstract
|
|
Dehais C, Laigle-Donadey F, Marie Y, Kujas M,
Lejeune J, Benouaich-Amiel A, Pedretti M, Polivka M, Xuan KH, Thillet J,
Delattre JY, Sanson M.
Prognostic stratification of patients with anaplastic gliomas according to
genetic profile.
Cancer. 2006 Sep 19; [Epub ahead of print]
Abstract
|
|
|
Orzan
F, Pellegatta S, Poliani L, Pisati F, Caldera V, Menghi F, Kapetis D, Marras
C, Schiffer D, Finocchiaro G.
Enhancer
of Zeste 2 (EZH2) is
up-regulated in malignant gliomas and in glioma stem-like cells.
Neuropathol Appl Neurobiol. 2010 Oct 8;. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Paugh
BS, Qu C, Jones C, Liu Z, Adamowicz-Brice M, Zhang J, Bax DA, Coyle B,
Barrow J, Hargrave D, Lowe J, Gajjar A, Zhao W, Broniscer A, Ellison DW,
Grundy RG, Baker SJ.
Integrated Molecular Genetic Profiling of Pediatric High-Grade Gliomas
Reveals Key Differences With the Adult Disease
J Clin Oncol. 2010 May 17;. [Epub ahead of print]
Abstract
|
|
|
Shirahata M, Iwao-Koizumi K, Saito S, Ueno N,
Oda M, Hashimoto N, Takahashi JA, Kato K
Gene expression-based molecular diagnostic system for malignant gliomas is
superior to histological diagnosis
Clin
Cancer Res. 2007 Dec 15;13(24):7341-56
Abstract
|
|
|
Gliomas
(Low-Grade)
|
|
|
|
|
Ferroli
P, Acerbi F, Finocchiaro G.
From standard treatment to personalized medicine: role of IDH1 mutations in
low-grade glioma evolution and treatment
World Neurosurg. 2010 Apr;73(4):234-6
Abstract |
Full Text |
Reprint |
Related articles
|
|
|
Mariani L, Deiana G, Vassella E, Fathi AR, Murtin
C, Arnold M, Vajtai I, Weis J, Siegenthaler P, Schobesberger M, Reinert MM.
Loss of Heterozygosity 1p36 and 19q13 Is a
Prognostic Factor for Overall Survival in Patients With Diffuse WHO Grade 2
Gliomas Treated Without Chemotherapy.
J
Clin Oncol. 2006 Sep 11; [Epub
ahead of print]
Abstract
|
|
Rorive S, Maris C, Debeir O, Sandras F, Vidaud M,
Bieche I, Salmon I, Decaestecker C.
Exploring the distinctive biological characteristics of pilocytic and
low-grade diffuse astrocytomas using microarray gene expression profiles.
J Neuropathol Exp Neurol. 2006 Aug;65(8):794-807.
Abstract
|
|
|
Medulloblastoma
|
|
|
|
De Bortoli M, Castellino RC, Lu XY, Deyo J, Sturla
LM, Adesina AM, Perlaky L, Pomeroy SL, Lau CC, Man
TK, Rao PH, Kim JY.
Medulloblastoma outcome is adversely
associated with overexpression of EEF1D, RPL30, and RPS20 on the long arm of
chromosome 8.
BMC Cancer. 2006 Sep 12;6(1):223 [Epub
ahead of print]
Abstract |
Reprint
|
|
|
De
Smaele E, Di Marcotullio L, Moretti M, Pelloni M, Occhione MA, Infante P,
Cucchi D, Greco A, Pietrosanti L, Todorovic J, Coni S, Canettieri G,
Ferretti E, Bei R, Maroder M, Screpanti I, Gulino A.
Identification and Characterization of KCASH2 and KCASH3, 2 Novel Cullin3
Adaptors Suppressing Histone Deacetylase and Hedgehog Activity in
Medulloblastoma.
Neoplasia. 2011 Apr;13(4):374-85.
Abstract |
Reprint |
Related articles
|
|
|
Korshunov A, Benner A, Remke M, Lichter P, von
Deimling A, Pfister S
Accumulation of genomic aberrations during clinical progression of
medulloblastoma
Acta
Neuropathol. 2008 Oct;116(4):383-90. Epub 2008 Aug 15
Abstract
|
Full Text
|
Reprint
|
|
|
McCabe
MG, Bäcklund LM, Leong HS, Ichimura K, Collins VP.
Chromosome 17 alterations identify good-risk and poor-risk tumors
independently of clinical factors in medulloblastoma.
Neuro Oncol. 2011 Feb 2;. [Epub ahead of print]
Abstract |
Reprint |
Related articles
|
|
K Urbanska, J Trojanek, L Del Valle,
M B Eldeen, F Hofmann, C Garcia-Echeverria, K Khalili and K Reiss
Inhibition of IGF-I receptor in
anchorage-independence attenuates GSK-3β constitutive phosphorylation and
compromises growth and survival of medulloblastoma cell lines
Oncogene. 2006 Oct 2; [Epub ahead of print]
Abstract
|
|
Pediatric
Patients
|
|
|
|
Parsons DW, Li M, Zhang X, Jones S, Leary RJ, Lin JC, Boca SM, Carter H,
Samayoa J, Bettegowda C, Gallia GL, Jallo GI, Binder ZA, Nikolsky Y,
Hartigan J, Smith DR, Gerhard DS, Fults DW, Vandenberg S, Berger MS, Marie
SK, Shinjo SM, Clara C, Phillips PC, Minturn JE, Biegel JA, Judkins AR,
Resnick AC, Storm PB, Curran T, He Y, Rasheed BA, Friedman HS, Keir ST,
McLendon R, Northcott PA, Taylor MD, Burger PC, Riggins GJ, Karchin R,
Parmigiani G, Bigner DD, Yan H, Papadopoulos N, Vogelstein B, Kinzler KW,
Velculescu VE.
The
Genetic Landscape of the Childhood Cancer Medulloblastoma.
Science.
2010 Dec 16. [Epub ahead of print]
Abstract |
News
|
Related articles
|
|
|
Meningioma
|
|
|
|
Hiroaki Okamoto, Jie Li,
Alexander O. Vortmeyer, Howard Jaffe, Youn-Soo
Lee, Sven Gläsker, Tae-Sung Sohn, Weifen
Zeng, Barbara Ikejiri, Martin A. Proescholdt,
Christina Mayer, Robert J. Weil, Edward H.
Oldfield and Zhengping Zhuang
Comparative Proteomic Profiles of Meningioma Subtypes
Cancer Res. 2006 Oct
15;66(20):10199-204.
Abstract
|
|
|
Stuart JE, Lusis EA, Scheck AC, Coons SW, Lal A, Perry A, Gutmann DH.
Identification
of Gene Markers Associated With Aggressive Meningioma by Filtering Across
Multiple Sets of Gene Expression Arrays.
J
Neuropathol Exp Neurol. 2010 Dec 11. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Metastatic Tumors
|
|
|
|
|
Zohrabian
VM, Nandu H, Gulati N, Khitrov G, Zhao C, Mohan A, Demattia J, Braun A, Das
K, Murali R, Jhanwar-Uniyal M.
Gene expression profiling of metastatic brain cancer.
Oncol Rep. 2007
Aug;18(2):321-8.
PMID: 17611651 [PubMed - in process]
|
|
|
Neuroblastoma
|
|
|
|
|
John
M. Maris, M.D., Yael P. Mosse, M.D., Jonathan P. Bradfield, B.S., Cuiping
Hou, B.S., Stefano Monni, Ph.D., Richard H. Scott, M.B., B.S., Shahab
Asgharzadeh, M.D., Edward F. Attiyeh, M.D., Sharon J. Diskin, Ph.D., Marci
Laudenslager, B.S., Cynthia Winter, B.A., Kristina A. Cole, M.D., Ph.D.,
Joseph T. Glessner, M.S., Cecilia Kim, B.A., Edward C. Frackelton, B.A.,
Tracy Casalunovo, M.S., Andrew W. Eckert, M.S., Mario Capasso, Ph.D., Eric
F. Rappaport, Ph.D., Carmel McConville, Ph.D., Wendy B. London, Ph.D.,
Robert C. Seeger, M.D., Nazneen Rahman, M.D., Ph.D., Marcella Devoto, Ph.D.,
Struan F.A. Grant, Ph.D., Hongzhe Li, Ph.D., and Hakon Hakonarson, M.D.,
Ph.D.
Chromosome 6p22 Locus Associated with Clinically
Aggressive Neuroblastoma
N
Engl J Med, Published
at www.nejm.org May 7, 2008 (10.1056/NEJMoa0708698)
Abstract |
Full Text |
Reprint |
News
|
|
|
Oligodendroglial
Tumors |
|
|
|
Alba A. Brandes, Alicia
Tosoni, Giovanna Cavallo, Michele Reni, Enrico
Franceschi, Laura Bonaldi, Roberta Bertorelle, Marina
Gardiman, Claudio Ghimenton, Paolo Iuzzolino, Annalisa
Pession, Valeria Blatt, Mario Ermani
Correlations Between O6-Methylguanine DNA
Methyltransferase Promoter Methylation Status, 1p and 19q Deletions, and
Response to Temozolomide in Anaplastic and Recurrent Oligodendroglioma: A
Prospective GICNO Study
J
Clin Oncol. 2006 Oct 10;24(29):4746-53. Epub 2006 Sep 5. DOI:
10.1200/JCO.2006.06.3891
|
|
|
Woehrer A, Sander P, Haberler C, Kern S, Maier H, Preusser M, Hartmann C,
Kros JM, Hainfellner JA; Research Committee of the European Confederation of
Neuropathological Societies.
FISH-based
detection of 1p 19q codeletion in oligodendroglial tumors: procedures and
protocols for neuropathological practice - a publication under the auspices
of the Research Committee of the European Confederation of Neuropathological
Societies (Euro-CNS).
Clin Neuropathol.
2011 Mar-Apr;30(2):47-55.
Abstract
|
Reprint
|
Related
articles
|
|
|
Pediatric
Patients |
|
|
|
|
Jacobs JF, Grauer OM, Brasseur F, Hoogerbrugge PM, Wesseling P, Gidding CE, van de
Rakt MW, Figdor CG, Coulie PG, de Vries IJ, Adema GJ
Selective cancer-germline gene expression in pediatric brain tumors
J Neurooncol. 2008 Apr 9; [Epub ahead of print]
Abstract |
Full Text |
Reprint |
Supplemental
Data
|
|
|
Liang ML, Ma J, Ho M, Solomon L, Bouffet E,
Rutka JT, Hawkins C.
Tyrosine kinase expression in pediatric high grade astrocytoma
J Neurooncol.
2008 May;87(3):247-53.
Epub 2008 Jan 10
Abstract
|
|
|
Pilocytic
Astrocytoma |
|
|
|
Addo-Yobo SO, Straessle J, Anwar A, Donson AM,
Kleinschmidt-Demasters BK, Foreman NK.
Paired overexpression of ErbB3 and Sox10 in pilocytic astrocytoma.
J Neuropathol Exp Neurol. 2006 Aug;65(8):769-75.
Abstract
|
|
|
Taillibert S, Vincent LA, Granger B, Marie Y,
Carpentier C, Guillevin R, Bellanger A, Mokhtari K, Rousseau A, Psimaras D,
Dehais C, Sierra del Rio M, Meng Y, Laigle-Donadey F, Hoang-Xuan K, Sanson
M, Delattre JY
Pilocytic
astrocytoma of the optic pathway: a tumour deriving from radial glia cells
with a specific gene signature
Brain.
2009 Jun;132(Pt 6):1523-35. Epub 2009 Mar 31
Abstract
|
|
|
Primary
CNS Lymphoma
|
|
|
|
Schwindt H, Akasaka T, Zuhlke-Jenisch R, Hans V, Schaller
C, Klapper W, Dyer MJ, Siebert R, Deckert M.
Chromosomal translocations fusing the BCL6 gene to different partner loci are
recurrent in primary central nervous system lymphoma and may be associated with
aberrant somatic hypermutation or defective class switch recombination.
J Neuropathol Exp Neurol. 2006 Aug;65(8):776-82.
Abstract
|
|
|
PNET
|
|
|
|
|
Kampman WA, Kros JM, De Jong TH,
Lequin MH
Primitive neuroectodermal tumours (PNETs) located in the spinal
canal; the relevance of classification as central or peripheral
PNET : case report of a primary spinal PNET occurrence with a
critical literature review.
J Neurooncol. 2006 Mar;77(1):65-72. Epub 2005 Nov 15.
Abstract
|
|
